Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Well Known Equity Indices are widely watched benchmarks that reflect overall market performance. This intro explains what they measure and why investors track them.
20,004 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
A new Goldman Sachs retirement survey projects retirement costs could climb to about $2.57 million by 2043, underscor...
Susquehanna lifts Cloudflare to a $200 price target as the AI-first reset takes shape. The stock sits near $196 after...
Stocks rally as AI names lead gains, but one gauge shows extraordinary greed. Investors weigh Buffett's caution again...
Midweek clarity can turn headlines into smart moves. This article curates practical wednesday reads that help investo...
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...
MercadoLibre reports a robust Q1 2026 with revenue rising sharply, even as margins compress. Analysts increasingly vi...
Explore how Pixelworks PXLW 2026 earnings shape a small-cap tech stock. This guide breaks down the key metrics, poten...
Baird & Warner announces a leadership shift, elevating Lucy Baird to Chief Stewardship Officer and Laura Ellis to Chi...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
OpenAI's latest media investment marks a shift toward humanity-centric assets, as deals reshape how investors value c...
KeyBanc boosts Okta's target to $103 from $95, citing a brighter security spending outlook and the central role of id...